StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.18+0.01 (+0.85%)

Close on Nov 16, 2026Market cap $85.31MP/E –Yield –

InflaRx cash

Cash and short-term investments held at the end of each period.

InflaRx's cash was €16.02M at Dec 31, 2025. For fiscal 2025 it was €16.02M, down 12.8% from the year before. Over ten years it grew 17.1% a year on average. The highest annual figure on record is €123.28M in fiscal 2017.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025€16.02M-12.8%
FY2024Dec 31, 2024€18.38M+43.9%
FY2023Dec 31, 2023€12.77M-21.5%
FY2022Dec 31, 2022€16.27M-38.0%
FY2021Dec 31, 2021€26.25M+1.1%
FY2020Dec 31, 2020€25.97M-21.6%
FY2019Dec 31, 2019€33.13M-40.2%
FY2018Dec 31, 2018€55.39M-55.1%
FY2017Dec 31, 2017€123.28M+323.4%
FY2016Dec 31, 2016€29.12M+781.8%
FY2015Dec 31, 2015€3.30M-50.1%
FY2014Dec 31, 2014€6.62M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025€16.02M+25.5%
Q2 FY2025Jun 30, 2025€13.00M-33.4%
Q4 FY2024Dec 31, 2024€18.38M+13.0%
Q2 FY2024Jun 30, 2024€19.15M+24.2%
Q4 FY2023Dec 31, 2023€12.77M-51.4%
Q2 FY2023Jun 30, 2023€19.52M-73.0%
Q4 FY2022Dec 31, 2022€16.27M-37.4%
Q2 FY2022Jun 30, 2022€15.42M-53.5%
Q4 FY2021Dec 31, 2021€26.25M-51.4%
Q2 FY2021Jun 30, 2021€72.36M+30.6%
Q4 FY2020Dec 31, 2020€25.97M-83.4%
Q4 FY2019Dec 31, 2019€33.13M-73.1%
Q2 FY2019Jun 30, 2019€54.06M+85.7%
Q4 FY2018Dec 31, 2018€55.39M+1577.4%
Q2 FY2018Jun 30, 2018€156.07M+2256.8%
Q4 FY2017Dec 31, 2017€123.28M–
Q4 FY2016Dec 31, 2016€29.12M–
Q4 FY2015Dec 31, 2015€3.30M–
Q4 FY2014Dec 31, 2014€6.62M–

More InflaRx figures

See a number that looks wrong?